财务摘要(报告期)(Amneal Pharmaceuticals Inc-A)
2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|
每股指标: | ||||||
每股收益EPS基本(元) | 0.03 | -0.05 | -0.86 | -0.83 | -0.82 | -0.01 |
每股净资产(元) | 1.14 | 0.96 | 0.98 | 0.98 | 0.92 | 1.29 |
每股经营现金净流量(元) | 0.42 | 0.46 | 0.21 | 0.29 | -0.02 | 0.40 |
每股现金流量净额(元) | 0.26 | 0.38 | -0.73 | -0.53 | -0.52 | -0.13 |
每股营业收入(元) | 3.78 | 1.83 | 7.29 | 5.28 | 3.48 | 1.64 |
盈利能力: | ||||||
销售毛利率(%) | 34.43 | 31.96 | 35.47 | 35.53 | 35.49 | 35.08 |
销售净利率(%) | 1.69 | -1.81 | -11.52 | -15.53 | -23.32 | -1.30 |
净资产收益率平均(%) | 1.48 | -2.25 | -39.46 | -38.20 | -38.39 | -0.57 |
总资产净利率(%) | 0.13 | -0.19 | -3.36 | -3.22 | -3.08 | -0.06 |
投入资本回报率ROIC(%) | 0.13 | -0.19 | -3.45 | -3.33 | -3.19 | -0.06 |
收益质量: | ||||||
营业利润/利润总额(%) | 566.04 | -365.47 | 38.26 | 54.46 | 72.25 | -234.91 |
税项/利润总额(%) | 3.19 | - | - | - | - | - |
经营活动产生的现金流量净额/营业收入(%) | 11.10 | 25.06 | 2.94 | 5.52 | -0.49 | 24.18 |
资本结构: | ||||||
资产负债率(%) | 95.06 | 95.53 | 94.50 | 94.41 | 95.28 | 89.10 |
权益乘数 | 20.24 | 22.36 | 18.18 | 17.88 | 21.17 | 9.18 |
产权比率 | 10.04 | 11.77 | 12.03 | 12.29 | 13.74 | 8.86 |
流动资产/总资产(%) | 38.42 | 36.05 | 37.16 | 36.65 | 38.44 | 35.73 |
非流动资产/总资产(%) | 61.58 | 63.95 | 62.84 | 63.35 | 61.56 | 64.27 |
流动负债/负债合计(%) | 22.10 | 20.31 | 20.97 | 22.37 | 25.79 | 17.37 |
非流动负债/负债合计(%) | 77.90 | 79.69 | 79.03 | 77.63 | 74.21 | 82.63 |
归属母公司股东的权益/投入资本(%) | 9.32 | 8.15 | 7.73 | 7.69 | 6.94 | 10.73 |
偿债能力: | ||||||
流动比率 | 1.83 | 1.86 | 1.88 | 1.74 | 1.56 | 2.31 |
速动比率 | 1.12 | 1.11 | 1.17 | 1.07 | 1.03 | 1.46 |
货币资金/流动负债(%) | 14.06 | 20.56 | 3.45 | 10.68 | 9.26 | 34.96 |
营业利润/流动负债(%) | 14.73 | 4.90 | -12.61 | -16.01 | -17.65 | 3.87 |
经营活动产生的现金流量净额/流动负债(%) | 16.51 | 19.85 | 8.65 | 10.81 | -0.52 | 19.99 |
归属母公司股东的权益/负债合计(%) | 9.96 | 8.50 | 8.31 | 8.13 | 7.28 | 11.29 |
经营活动产生的现金流量净额/负债合计(%) | 3.65 | 4.03 | 1.81 | 2.42 | -0.13 | 3.47 |
营业利润/负债合计(%) | 3.26 | 0.99 | -2.64 | -3.58 | -4.55 | 0.67 |
成长能力: | ||||||
总资产同比增长率(%) | -8.43 | -6.75 | -3.56 | -2.53 | 0.46 | -1.80 |
每股净资产同比增长率(%) | 23.79 | -25.35 | -17.75 | -15.73 | -19.54 | 20.26 |
总负债同比增长率(%) | -8.64 | -0.02 | 0.97 | 2.28 | 6.41 | -3.22 |
基本每股收益同比增长率(%) | 103.66 | -400.00 | -1,328.57 | -854.55 | -685.71 | -120.00 |
归属母公司股东的权益同比增长率(%) | 24.95 | -24.73 | -17.18 | -15.13 | -19.01 | 21.09 |
营业利润同比增长率(%) | 165.33 | 47.82 | -162.16 | -192.52 | -255.11 | -49.23 |
营业收入同比增长率(%) | 9.42 | 12.04 | 5.67 | 2.94 | 2.80 | 0.92 |
股东权益合计同比增长率(%) | -4.19 | -61.73 | -45.57 | -45.62 | -52.80 | 11.60 |
营运能力: | ||||||
存货周转率次(次) | 1.40 | 0.72 | 2.80 | 2.00 | 1.33 | 0.65 |
流动资产周转率次(次) | 0.82 | 0.41 | 1.51 | 1.09 | 0.69 | 0.34 |
固定资产周转率次(次) | 2.49 | 1.20 | 4.50 | 3.26 | 2.12 | 0.98 |
总资产周转率次(次) | 0.31 | 0.15 | 0.57 | 0.41 | 0.26 | 0.13 |
衍生指标: | ||||||
现金及现金等价物净增加额TTM(元) | 16,400,000.00 | -65,476,000.00 | -221,512,000.00 | -214,728,000.00 | -184,971,000.00 | -239,269,000.00 |
利润总额TTM(元) | 14,759,000.00 | -247,632,000.00 | -248,127,000.00 | -256,791,000.00 | -261,014,000.00 | 6,541,000.00 |
毛利TTM(元) | 807,825,000.00 | 788,323,000.00 | 784,708,000.00 | 735,722,000.00 | 740,003,000.00 | 751,982,000.00 |
投入资本(元) | 3,759,003,000.00 | 3,614,150,000.00 | 3,862,858,000.00 | 3,867,509,000.00 | 4,038,877,000.00 | 3,645,789,000.00 |
经营活动产生的现金流量净额TTM(元) | 198,645,000.00 | 84,469,000.00 | 65,100,000.00 | 151,653,000.00 | 140,447,000.00 | 214,035,000.00 |
总营业收入TTM(元) | 2,311,902,000.00 | 2,272,211,000.00 | 2,212,304,000.00 | 2,139,441,000.00 | 2,122,477,000.00 | 2,098,197,000.00 |
归属母公司净利润TTM(元) | -2,048,000.00 | -134,773,000.00 | -129,986,000.00 | -132,030,000.00 | -133,578,000.00 | 1,762,000.00 |
所得税TTM(元) | 3,418,000.00 | 10,791,000.00 | 6,662,000.00 | 12,599,000.00 | 12,078,000.00 | 7,376,000.00 |